PuraCath Medical Presents Data at National Kidney Foundation 2016 Spring Clinical Meetings

Boston, Massachusetts (April 28, 2016) – PuraCath Medical, an emerging company in the development of technologies to reduce infections in patients with intravascular and peritoneal catheters, announced today that it presented data on its next generation version of the FireFly™ Peritoneal Dialysis (PD) Connector Disinfecting System during the National Kidney Foundation’s 2016 Spring Clinical Meetings held in Boston, Massachusetts.  The data presented confirms the effectiveness of the 2nd generation version of the company’s ultraviolet (UV) system for disinfecting peritoneal dialysis (PD) connections achieving a greater than 4-log reduction in microorganisms which are commonly associated with peritonitis in patients receiving PD therapy. The National Kidney Foundation meeting is being attended by over 3,000 healthcare professionals involved in the management and care of patients with renal disease.

Peritonitis remains a serious complication for PD patients and represents the leading cause of technique failure,” said Julia Rasooly, PuraCath Medical’s CEO. “While there have been improvements in PD connectors and connection methods which reduce PD infection risk, air and touch contamination during PD exchanges continue to be significant cause of peritonitis. We believe our FireFly technology will provide PD patients with an easy-to-use, patient friendly option for reducing bacterial and fungal contamination during PD exchanges.”

The FireFly PD Connector Disinfecting System recently received U.S. Food and Drug Administration 510(k) clearance and is intended for use by patients as a method of controlling air and touch contamination while performing PD exchanges. PuraCath Medical is currently offering the device for sale via a limited market release.